David Rosenthal
Psychiatry · Boulder, CONPI 1104195817
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 321 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 321 payments — averaging $30.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- AbbVie$1K
- Alkermes, Inc.$856
- Vanda Pharmaceuticals Inc.$698
- Ironshore Pharmaceuticals Inc.$541
- plus $3K from 19 others
What the payments were for
- Food & beverage$9,83999%
- Education$891%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 28 | $1,693 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 47 | $1,531 |
| AbbVie(2 entities) | 67 | $1,474 |
| Alkermes, Inc. | 26 | $856 |
| Vanda Pharmaceuticals Inc. | 21 | $698 |
| Ironshore Pharmaceuticals Inc. | 23 | $541 |
| Corium, LLC | 16 | $425 |
| E.r. Squibb & Sons, L.L.C. | 9 | $421 |
| Otsuka America Pharmaceutical, Inc. | 9 | $372 |
| Tris Pharma Inc | 12 | $346 |
| Axsome Therapeutics, Inc. | 5 | $275 |
| Johnson & Johnson | 3 | $238 |
| Idorsia Pharmaceuticals US Inc | 6 | $188 |
| Supernus Pharmaceuticals, Inc. | 6 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $155 |
| Alfasigma USA, Inc. | 9 | $114 |
| Janssen Scientific Affairs, LLC | 1 | $90 |
| Bausch Health US, LLC | 6 | $82 |
| Lundbeck LLC | 4 | $67 |
| Eisai Inc. | 4 | $64 |
| Shire North American Group Inc | 3 | $41 |
| Neos Therapeutics, LP | 2 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $14 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,929 in reported general payments places this provider in the 95th percentile of 559 psychiatry providers in Colorado.
Other psychiatry in Boulder
- Teri CarlsonBoulder$10K
- Gerald ChittersBoulder$3K
- John HardyPueblo$828K
- Larry SandersLittleton$760K
- Jeffrey RichmondDenver$424K
- Jennifer FrenchGlendale$115K
- Charles ParkLone Tree$89K
- Cynthia EppersonAurora$64K
- Brian WiseCentennial$44K
- Robert CowanCentennial$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.